Disorders of sex development
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Normal sex development depends on the precise spatio-temporal sequence and coordination of mutually antagonistic activating and repressing factors. These factors regulate the commitment of the unipotential gonad into the binary pathways governing normal sex development. Typically, the presence of the SRY gene on the Y chromosome triggers the cascade of molecular events leading to male sex development. Disorders of sex development comprise a heterogenous group of congenital conditions associated with atypical development of internal and external genitalia. These disorders are generally attributed to deviations from the typical progression of sex development. Disorders of sex development can be classified into several categories including chromosomal, gonadal, and anatomic abnormalities. Genetic tools such as microarray analyses and next-generation sequencing techniques have identified novel genetic variants among patients with DSD. Most importantly, patient management needs to be individualized especially for decisions related to sex of rearing, surgical interventions, hormone treatment, and potential for fertility preservation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Nielsen, J., & Wohlert, M. (1991) · Human Genetics · doi:10.1007/bf01213097 · Cited by 1,193 · cited 1×
“The reported incidence is 1 in 2500 live-born female birth [32].”
BackgroundGravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101 · cited 1×
“Estrogen and progesterone hormone therapy are essential to promote development of secondary sexual characteristics and prevent osteopenia [34].”
BackgroundFlück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248 · cited 1×
“The genes encoding these proteins include SF1 (NR5A1), LH receptor (LHR), steroidogenic acute regulatory peptide (StAR), cholesterol desmolase (CYP11A1), 17α-hydroxylase/17,20-lyase (CYP17A1), 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2), 17β-hydroxysteroid dehydrogenase type 3 (HSD17B3), 3α-hydroxysteroid dehydrog…”
BackgroundGenotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163 · cited 1×
“Paradoxically, male infants with HSD3B2 and POR mutations may present with undervirilization due to impaired testosterone biosynthesis [19].”
BackgroundThe Turner syndrome life course project: karyotype-phenotype analyses across the lifespan
Cameron‐ Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C., & Conway, G. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13394 · Cited by 161 · cited 1×
“The likelihood for development of these co-morbidities is greatest in the girls with 45,X karyotype [33].”
BackgroundSexual function and attitudes toward surgery after feminizing genitoplasty
Fagerholm, R., Santtila, P., Miettinen, P. J., Mattila, A., Rintala, R., & Taskinen, S. (2011) · Journal of Urology · doi:10.1016/j.juro.2010.12.099 · Cited by 99
Binet, A., Lardy, H., Geslin, D., Francois-Fiquet, C., & Poli-Merol, M. L. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.10.004 · Cited by 91
Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice
Zhao, F., Franco, H. L., Rodriguez, K. F., Brown, P. R., Tsai, M.-J., Tsai, S. Y., & Yao, H. H.-C. (2017) · Science · doi:10.1126/science.aai9136 · Cited by 86 · cited 1×
“Recent data derived from mouse studies suggest that the orphan nuclear receptor, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) may play an active role in eliminating the Wolffian ducts in females [16].”
Background
Cited by
Bhargava, A., Arnold, A. P., Bangasser, D. A., Denton, K. M., Gupta, A., Hilliard Krause, L. M., Mayer, E. A., McCarthy, M., Miller, W. L., Raznahan, A., et al. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa034 · Cited by 130
Metadata
- Authors
- Witchel, S. F.
- Venue
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 48
- Pages
- 90-102
- ISSN
- 1521-6934 (ISSN-L)
- OpenAlex
- W2769332942
- Cited by
- 193
- References
- 9
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.